Selected article for: "CT Computed tomography and ground glass"

Author: Soriano Aguadero, I.; Ezponda Casajús, A.; Mendoza Ferradas, F.; Igual Rouilleault, A.; Paternain Nuin, A.; Pueyo Villoslada, J.; Bastarrika Alemañ, G.
Title: Chest computed tomography findings in different phases of SARS-CoV-2 infection
  • Cord-id: 8s6l0sxe
  • Document date: 2021_4_2
  • ID: 8s6l0sxe
    Snippet: Objective To compare the findings on chest computed tomography (CT) in patients with COVID-19 during different phases of the disease and to evaluate the reproducibility of a visual radiologic score for estimating the extent of lung involvement. Methods We retrospectively reviewed chest CT studies from 182 patients with RT-PCR findings positive for SARS-CoV-2. Patients were classified according to the time elapsed from the onset of symptoms, as follows: early (0-4 days), intermediate/progressive
    Document: Objective To compare the findings on chest computed tomography (CT) in patients with COVID-19 during different phases of the disease and to evaluate the reproducibility of a visual radiologic score for estimating the extent of lung involvement. Methods We retrospectively reviewed chest CT studies from 182 patients with RT-PCR findings positive for SARS-CoV-2. Patients were classified according to the time elapsed from the onset of symptoms, as follows: early (0-4 days), intermediate/progressive (5-9 days), or advanced (≥10 days). We analyzed the frequency of each radiologic finding, as well as the pattern, appearance, and predominant distribution of lung involvement. A visual tomographic score (range, 0-25) was used to estimate the extent of involvement in each lobe and in the total lung volume. Results The predominant CT finding was the ground-glass pattern (n = 110; 60.4%), the most common distribution was peripheral (n = 116; 66.7%), and the most prevalent appearance was typical (n = 112; 61.5%). The halo sign was seen most frequently in the early phase (25%), whereas ground-glass opacities were more common in the intermediate/progressive and advanced phases. The median severity score was 10 (IQR: 5-13), and the scores increased as the disease progressed. The interobserver agreement (kappa) was 0.92 for the appearance, 0.84 for the distribution, 0.70 for the predominant pattern, and 0.89 for the visual score. Conclusion The CT findings in patients with COVID-19 vary with the course of the infection. The proposed visual radiologic score is a simple, reproducible, and reliable tool for assessing lung involvement in COVID-19 pneumonia.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and add prognostic value: 1
    • acute respiratory syndrome and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lobe score: 1, 2, 3, 4
    • acute respiratory syndrome and lobe volume: 1
    • acute respiratory syndrome and lung abnormality: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung involvement extent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome and lung involvement extent estimate: 1
    • additional information and admission time: 1, 2, 3
    • additional information and lung involvement: 1, 2
    • additional information and lung involvement extent: 1
    • admission time and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • admission time and lung involvement extent: 1, 2, 3, 4, 5
    • admission time and lung involvement extent quantify: 1
    • lobe score and lung involvement: 1, 2, 3, 4, 5, 6
    • lobe volume and lung involvement: 1, 2
    • lobe volume and lung involvement extent: 1
    • lobe volume and lung involvement extent estimate: 1